RUNIMOTAMAB

UNII:	F8Z9VSZ0K1
Formula:
Preferred Substance Name:	RUNIMOTAMAB
GSRS Full Record:	F8Z9VSZ0K1 i

2361325-98-4
ANTI-HER2/CD3 TDB
BTRC4017A
BTRC-4017A
HER2/CD3 TDB
IMMUNOGLOBULIN G1 (300-GLYCINE,369-TRYPTOPHAN), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2) (HUMAN MONOCLONAL KTRC5520 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL KTRC5520 .KAPPA.-CHAIN, (229->228'),(232->231')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (299-GLYCINE,368-SERINE,370-ALANINE,409-VALINE) ANTI-(HUMAN CD3 ANTIGEN) (HUMAN MONOCLONAL HTHR4765 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN MONOCLONAL HTHR4765 .KAPPA.-CHAIN
RG-6194
RO7227780
RO-7227780
RUNIMOTAMAB [INN]
RUNIMOTAMAB [USAN]
RUNIMOTAMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RUNIMOTAMAB

Synonyms and Mappings

Resources